Large ENvue Medical (FEED) stake: investor reports owning 22.05% of shares

Rhea-AI Filing Summary

ENvue Medical, Inc. shareholder Christian Michael Glibert filed a Schedule 13D disclosing beneficial ownership of 240,000 shares of common stock, representing about 22.05% of the company based on 1,088,192 shares outstanding as of February 2026. On January 14, 2026, he purchased 240,000 shares in an open market transaction at an average price of $2.67 per share, using personal funds totaling approximately $640,737.85. He states the shares were acquired for investment purposes and that he may buy more or sell some in the future, but reports no current plans for corporate actions and no contracts or arrangements with others regarding the issuer’s securities.

Insights

Equity ownership & governance analyst

Large 22% stake disclosed by individual investor using personal funds.

Christian Michael Glibert now reports beneficial ownership of 240,000 ENvue Medical common shares, or about 22.05% of the company. The entire position was acquired in a single open market purchase on January 14, 2026 at an average price of $2.67 per share.

The filing describes the purchase as being for investment purposes, funded with approximately $640,737.85 of personal capital. It also notes there are no contracts or understandings with other parties regarding ENvue Medical’s securities, and no present plans for transactions such as mergers, asset sales, or changes in control.

Future changes in Glibert’s holdings would be reflected in subsequent beneficial ownership filings if thresholds are met, while ENvue’s total shares outstanding are stated as 1,088,192 as of February 2026, providing context for the scale of this stake within the company’s equity base.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

ENvue Medical, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

29415F100

(CUSIP Number)

Christian Glibert
4001 Green Heron Spring Drive,
Carpinteria, CA, 93013
740-507-7228

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

01/14/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. 29415F100

1

Name of reporting person

Glibert Christian Michael

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 240,000.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 240,000.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

240,000.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

22.0 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, par value $0.001 per share
(b)	Name of Issuer: ENvue Medical, Inc.
(c)	Address of Issuer's Principal Executive Offices: 969 PRUITT AVE,, TYLER, TEXAS , 77569.
Item 2.	Identity and Background
(a)	Christian Michael Glibert
(b)	4001 Green Heron Spring Drive, Carpinteria CA 93013
(c)	Physical Therapist, investor.
(d)	none
(e)	none
(f)	United States of America
Item 3.	Source and Amount of Funds or Other Consideration
	Source: Personal Funds. Amount: $640,737.85 The source of funds for the purchase of the Common Stock was personal funds of the Reporting Person. No part of the purchase price was represented by funds or other consideration borrowed or otherwise obtained for the purpose of acquiring, holding, trading, or voting the securities.
Item 4.	Purpose of Transaction
	The Reporting Person acquired the Common Stock for investment purposes. Depending on market conditions and other factors, the Reporting Person may from time to time acquire additional securities of the Issuer or dispose of all or a portion of the securities. Except as set forth above, the Reporting Person has no present plans or proposals which relate to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D.
Item 5.	Interest in Securities of the Issuer
(a)	Aggregate Number: 240,000 Percentage: 22.05% (Based on 1,088,192 shares outstanding as of Feb 2026).
(b)	Sole Voting Power: 240,000 Shared Voting Power: 0 Sole Dispositive Power: 240,000 Shared Dispositive Power: 0
(c)	Recent Transactions: On January 14, 2026, the Reporting Person purchased 240,000 shares at average $2.67 price per share in an open market transaction.
(d)	Not applicable
(e)	Not applicable
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	There are no contracts, arrangements, understandings, or relationships (legal or otherwise) between the Reporting Person and any other person with respect to any securities of the Issuer.
Item 7.	Material to be Filed as Exhibits.
	None

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Glibert Christian Michael

Signature:	/s/ Christian Michael Glibert
Name/Title:	Individual
Date:	02/11/2026

FAQ

What does Christian Michael Glibert’s Schedule 13D filing reveal about ENvue Medical (FEED)?

The Schedule 13D shows Christian Michael Glibert beneficially owns 240,000 ENvue Medical shares, about 22.05% of the company. This large stake gives him significant influence as a shareholder, based on 1,088,192 shares outstanding as of February 2026.

How many ENvue Medical (FEED) shares did Christian Michael Glibert buy and at what price?

Christian Michael Glibert purchased 240,000 ENvue Medical common shares on January 14, 2026, in an open market trade. The average purchase price was $2.67 per share, implying a total investment of approximately $640,737.85 funded from his personal resources.

What percentage of ENvue Medical (FEED) does Christian Michael Glibert now own?

According to the filing, Christian Michael Glibert beneficially owns about 22.05% of ENvue Medical’s common stock. This percentage is calculated from his 240,000 shares relative to 1,088,192 shares of common stock outstanding as of February 2026, as cited in the disclosure.

Why did Christian Michael Glibert acquire ENvue Medical (FEED) shares according to the filing?

The filing states that Christian Michael Glibert acquired ENvue Medical common stock for investment purposes. It notes he may buy additional securities or sell part of his holdings depending on market conditions and other factors, but lists no specific corporate plans or proposals.

How did Christian Michael Glibert fund his ENvue Medical (FEED) share purchase?

The Schedule 13D explains that the ENvue Medical shares were bought using Glibert’s personal funds. The amount spent was approximately $640,737.85, and no part of the purchase price came from borrowed funds or other consideration obtained to acquire, hold, trade, or vote the securities.

Does Christian Michael Glibert have any agreements related to his ENvue Medical (FEED) stake?

The filing reports there are no contracts, arrangements, understandings, or relationships between Christian Michael Glibert and any other person regarding ENvue Medical securities. It also notes he currently has no plans for actions such as mergers, asset sales, or changes in control involving the company.